ArticleCancers2023
Infliximab for Treatment of Immune Adverse Events and Its Impact on Tumor Response.
Vishnupriyadevi Parvathareddy et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
12 papers cite it
this paperpooled itcites it